Comments on the responses of Utteridge et al. (Radiat. Res. 159, 277-278, 2003) to letters about their paper (Radiat. Res. 158, 357-364, 2002).
Kundi
Michael
M
D000236:Adenoma / Q000209:etiology / Q000235:genetics; D000818:Animals; D001984:Bronchial Neoplasms / Q000209:etiology / Q000235:genetics; D002386:Cataract / Q000209:etiology / Q000235:genetics; D004307:Dose-Response Relationship, Radiation; D004781:Environmental Exposure; D005260:Female; D020022:Genetic Predisposition to Disease; D005921:Glomerulonephritis / Q000209:etiology / Q000235:genetics; D006390:Hemangioendothelioma / Q000209:etiology / Q000235:genetics; D008223:Lymphoma / Q000209:etiology* / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D008822:Mice, Transgenic; D008872:Microwaves / Q000009:adverse effects*; D009381:Neoplasms, Radiation-Induced / Q000209:etiology* / Q000235:genetics; D010911:Pituitary Neoplasms / Q000209:etiology / Q000235:genetics; D017346:Protein Serine-Threonine Kinases / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D011518:Proto-Oncogene Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D013160:Splenic Neoplasms / Q000209:etiology / Q000235:genetics
D011518:Proto-Oncogene Proteins; D017346:Protein Serine-Threonine Kinases